AGG Partner Alan G. Minsk wrote an article that ran on May 20th on eyeforpharma, a London-based website that promotes discussion of pharmaceutical industry issues. The article, “Market Access: Figuring Out the FDA” and discusses the complex task of seeking approval from the US Food and Drug Administration (FDA). Mr. Minsk offers several useful tips to make the process easier and more efficient. He cautions about use of bold marketing claims that use clinical data, and advises companies to keep it simple when seeking FDA approval. He writes that the FDA’s main concern is product safety, not time and money spent by the applicant. To read the full article, please click here.